Metsera

Metsera Net Debt / EBITDA

Delisted

The Net Debt to EBITDA of Metsera (MTSR) as of Nov 3, 2026 is 1.53. In the previous year, Net Debt to EBITDA was 1.72 — a change of -11.13% (lower).

Net Debt / EBITDA

1.53

YoY

-11.13%

Last updated:

Net Debt to EBITDA of Metsera is 2024 1.53 . Net Debt to EBITDA of Metsera was 2023 1.72 . It decreases by -11.13% lower compared to the previous year.

The Metsera Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2022
-0.30 USD
Jan 1, 2023
1.72 USD
Jan 1, 2024
1.53 USD
The Metsera Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
1.53-11.13%
1.72-674.26%
-0.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Net Debt to EBITDA of Metsera is 1.53 in 2024.

Net Debt to EBITDA of Metsera changed from 1.72 to 1.53, representing a -11.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Metsera since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Metsera with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Metsera

All Key Metrics — Metsera